Home > Insider Trading > Filing (0001021561-18-000032)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1021561	Nu Skin Enterprises Inc	NUS	Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)	870565309

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1231132	Matthew D Dorny	C/O Nu Skin Enterprises, Inc. 75 West Center Street Provo UT 84601	General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Disposition	2018-03-04	331	$72.35	44,399	No	4	F	Direct
Class A Common Stock	Acquisiton	2018-03-05	3,000	$39.35	47,399	No	4	M	Direct
Class A Common Stock	Disposition	2018-03-05	3,000	$72.69	44,399	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2018-03-02	16,138	$0.00	16,138	$30.63
Class A Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2018-03-02	8,339	$0.00	8,339	$50.68
Class A Common Stock	Employee Stock Option (Right to Buy)	Disposition	2018-03-05	3,000	$0.00	3,000	$39.35

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
32,934	2018-03-02	2023-03-02	No	4	A	Direct
8,339	2018-03-04	2024-03-04	No	4	A	Direct
3,250		2018-08-15	No	4	M	Direct

Footnotes

Shares witheld to cover tax witholding obligations related to the vesting of previously granted restricted stock units.
Sale pursuant to a 10b5-1 plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.32 to $73.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
On March 2, 2016, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On March 2, 2018, the performance criteria were met, resulting in the vesting of the amount shown above.
On March 4, 2017, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On March 2, 2018, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.
Currently exercisable in full.